The study is a prospective, controlled, randomised and assessor blind study that investigate if the need for bank blood transfusion could be reduced in patients, undergoing primary or revision total hip replacement surgery, who receive their own blood back with the medical device Sangvia. A comparison in need for bank blood will be made between patients that either receive their own blood back or not.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
227
Sangvia® Intra- and Post-op System
Medical University Vienna, Department of Orthopaedic Surgery
Vienna, Austria
Onze Lieve Vrouwe Gasthuis (OLVG)
Amsterdam, Netherlands
Reinier de Graaf Gasthuis (RdGG), afd. Orthopedie
Delft, Netherlands
MC Haaglanden, Orthopedic Dept.
The Hague, Netherlands
St. Olavs Hospital, Ortopedisk avdelning
Trondheim, Norway
Hospital Universitario Mar- Esperança (IMAS), Servicio de Anestesiología
Barcelona, Spain
Number of Participants in Need for Bank Blood Transfusion
Bank blood transfusions were given in both groups after assessment of independent assessor, by using a transfusion trigger. All transfusions were recorded in a transfusion log and summarized at discharge. The total number of patients per group in need for any bank blood transfusion was compared. The participant were followed for the duration of hospital stay, an average of 6 days (SD 3 days)
Time frame: At discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.